Gabelli Funds’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Gabelli Funds's KITE Position: Q4 2017 in Review
Gabelli Funds sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 622,232 shares — an estimated $112M sold.
Gabelli Funds first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $112M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Gabelli Funds reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Gabelli Funds sold 622,232 Kite Pharma, Inc. shares in Q4 2017, an estimated $112M.
- Gabelli Funds first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
- Gabelli Funds's Kite Pharma, Inc. position peaked at $112M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Gabelli Funds's 13F filing for Q4 2017, filed 2 Feb 2018.